Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial

Table 1 Timetable of prospective investigations

Investigation	Baseline	Post procedure	3 months	6 months	9 months	12 months	2 years	5 years
Medical/clinical history	x	x	x	x	x	x	x	x
Physical examination	x	x			x
12-lead ECG^a	x	x			x
Coronary angiogram^b	x				x
Procedural complications		x			x
Laboratory survey^c	x				x
CK, CK-MB, troponin^d		x			x
Medications	x	x	x	x	x	x	x	x
Primary outcome					x
Secondary outcome			x	x	x	x	x	x

^aAny ECG may be obtained when clinically relevant.
^bUnscheduled angiograms after 6 months will be considered 9-month follow-up angiograms.
^cUsual laboratory survey include, complete blood count, electrolytes, fasting glucose level, INR, prothrombin time, partial thromboplastin time, creatinine, blood urea nitrogen, pregnancy test if applicable.
^dAll patients will benefit from cardiac enzyme measurement 4 h post procedure, enzymes may be followed every 8 h if clinically relevant and at the discretion of the operator.
CK creatine kinase, ECG electrocardiogram.

ISSN: 1745-6215